6vtw

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (11:21, 30 October 2024) (edit) (undo)
 
Line 1: Line 1:
-
==De novo protein design enables the precise induction of RSV-neutralizing antibodies==
+
==Crystal Structure of a computationally designed Immunogen S4_2.45 in complex with 101F==
<StructureSection load='6vtw' size='340' side='right'caption='[[6vtw]], [[Resolution|resolution]] 2.60&Aring;' scene=''>
<StructureSection load='6vtw' size='340' side='right'caption='[[6vtw]], [[Resolution|resolution]] 2.60&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6vtw]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_respiratory_syncytial_virus_A2 Human respiratory syncytial virus A2] and [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6VTW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6VTW FirstGlance]. <br>
+
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6VTW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6VTW FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6&#8491;</td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6vtw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6vtw OCA], [https://pdbe.org/6vtw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6vtw RCSB], [https://www.ebi.ac.uk/pdbsum/6vtw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6vtw ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6vtw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6vtw OCA], [https://pdbe.org/6vtw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6vtw RCSB], [https://www.ebi.ac.uk/pdbsum/6vtw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6vtw ProSAT]</span></td></tr>
</table>
</table>
-
<div style="background-color:#fffaf0;">
 
-
== Publication Abstract from PubMed ==
 
-
De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.
 
- 
-
De novo protein design enables the precise induction of RSV-neutralizing antibodies.,Sesterhenn F, Yang C, Bonet J, Cramer JT, Wen X, Wang Y, Chiang CI, Abriata LA, Kucharska I, Castoro G, Vollers SS, Galloux M, Dheilly E, Rosset S, Corthesy P, Georgeon S, Villard M, Richard CA, Descamps D, Delgado T, Oricchio E, Rameix-Welti MA, Mas V, Ervin S, Eleouet JF, Riffault S, Bates JT, Julien JP, Li Y, Jardetzky T, Krey T, Correia BE Science. 2020 May 15;368(6492). pii: 368/6492/eaay5051. doi:, 10.1126/science.aay5051. PMID:32409444<ref>PMID:32409444</ref>
 
- 
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 
-
</div>
 
-
<div class="pdbe-citations 6vtw" style="background-color:#fffaf0;"></div>
 
==See Also==
==See Also==
*[[Antibody 3D structures|Antibody 3D structures]]
*[[Antibody 3D structures|Antibody 3D structures]]
-
== References ==
 
-
<references/>
 
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human respiratory syncytial virus A2]]
 
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Mus musculus]]
 
[[Category: Correia B]]
[[Category: Correia B]]
[[Category: Jardetzky T]]
[[Category: Jardetzky T]]

Current revision

Crystal Structure of a computationally designed Immunogen S4_2.45 in complex with 101F

PDB ID 6vtw

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools